Revolution Biosciences
Revolution BioSciences: Early-stage drug discovery firm offering bioanalytical services & MALDI MS products.
Founded
2015Revolution BioSciences: Early-stage drug discovery firm offering bioanalytical services & MALDI MS products.
Revolution BioSciences, founded in the greater Boston area, is an early-stage biopharmaceutical company dedicated to advancing drug discovery. The company's core mission is to accelerate the development of novel therapeutics through innovative bioanalytical services and cutting-edge MALDI TOF Mass Spectrometry (MS) products. Their offerings include assay development, high throughput screening, and lead optimization, catering primarily to the pharmaceutical and biotechnology sectors.
The team at Revolution BioSciences includes seasoned experts with extensive experience in the BioPharma industry. The company operates from a state-of-the-art laboratory, enabling them to deliver high-quality Contract Research Organization (CRO) services. Notable achievements include the development of robust and novel assays that have significantly impacted drug discovery processes. Through their specialized services and consulting expertise, Revolution BioSciences has established itself as a key player in the early-stage drug discovery market.
Companies similar to Revolution Biosciences include Accium BioSciences, LiVeritas Biosciences, BioAnalytix and RedShift BioAnalytics.
Revolution Biosciences was founded in 2015.
Revolution Biosciences' headquarters is located in Norwell, MA, US.
Revolution Biosciences' most recent funding round was for $195k (USD) in December 2015.
As of Dec 16, 2015, Revolution Biosciences has disclosed funding of $195k (USD). Undisclosed round amounts are excluded.
Revolution Biosciences has 2 employees as of Feb 4, 2024.
RedShift BioAnalytics
redshiftbio.com
